70 related articles for article (PubMed ID: 2977887)
1. Does circadian variation of "cathepsin B-like" activity exist in the serum of patients with lung cancer?
Vodvárka P; Kolár Z; Dufek V
Acta Univ Palacki Olomuc Fac Med; 1988; 120():153-60. PubMed ID: 2977887
[No Abstract] [Full Text] [Related]
2. Changes of serum proteinase "cathepsin B-like" activity in patients with lung cancer and plasmocytoma after therapy.
Vodvárka P; Kolár Z; Dufek V; Bacovský J; Krepela E
Acta Univ Palacki Olomuc Fac Med; 1988; 119():173-9. PubMed ID: 2977479
[No Abstract] [Full Text] [Related]
3. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E
Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic significance of serum proteinase activity ("cathepsin B-like" activity) testing by amino acid derivatives of 7-amino-4-methylcoumarine.
Kolár Z; Krepela E; Dufek V; Rypka M; Bacovský J; Vodvárka P; Kovarík J; Kohoutek M; Vicar J; Karhan J
Acta Univ Palacki Olomuc Fac Med; 1988; 119():161-72. PubMed ID: 2977478
[No Abstract] [Full Text] [Related]
5. Serum level of cathepsin B and its density in men with prostate cancer as novel markers of disease progression.
Miyake H; Hara I; Eto H
Anticancer Res; 2004; 24(4):2573-7. PubMed ID: 15330217
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence demonstration of cathepsin B-like cysteine proteinase activity in lung squamous cell carcinomas and surrounding tissues.
Kolár Z
Acta Univ Palacki Olomuc Fac Med; 1986; 114():203-9. PubMed ID: 2946180
[No Abstract] [Full Text] [Related]
7. [Cathepsin B activity and concentration of elastase and alpha-1 proteinase inhibitor complex in non-small-cell lung cancer: 2 year follow-up study].
Passowicz-Muszyńska E; Jankowska R; Gołab K; Marciniak M; Warwas M
Pol Merkur Lekarski; 2003 May; 14(83):417-20. PubMed ID: 12939816
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of increased lung tumor tissue cathepsin B.
Ebert W; Knoch H; Werle B; Trefz G; Muley T; Spiess E
Anticancer Res; 1994; 14(3A):895-9. PubMed ID: 8074490
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer.
Zore I; Krasovec M; Cimerman N; Kuhelj R; Werle B; Nielsen HJ; Brünner N; Kos J
Biol Chem; 2001 May; 382(5):805-10. PubMed ID: 11517934
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin B, thiols and cysteine protease inhibitors in squamous-cell lung cancer.
Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
Neoplasma; 1997; 44(4):219-39. PubMed ID: 9473776
[TBL] [Abstract][Full Text] [Related]
12. [Serum activity of chitotriosidase, lysozyme and cathepsin H in patients with lung cancer and patients with inflammatory exudate (preliminary report)].
Gołab K; Passowicz-Muszyńska E; Jankowska R; Warwas M
Pol Merkur Lekarski; 2009 Mar; 26(153):194-7. PubMed ID: 19388531
[TBL] [Abstract][Full Text] [Related]
13. A possible application of cathepsin B activity determination for estimating the spread of the cervix uteri carcinoma.
Makarewicz R; Drewa G
Acta Biochim Pol; 1996; 43(3):521-4. PubMed ID: 8922036
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with the testing of serum proteinase activity by cathepsin B-like sensitive amino acid derivatives of 7-amino-4-methylcoumarine.
Kolár Z; Krepela E; Kovarík J; Kohoutek M; Rypka M; Vicar J
Neoplasma; 1987; 34(5):601-8. PubMed ID: 3122064
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.
Werle B; Kotzsch M; Lah TT; Kos J; Gabrijelcic-Geiger D; Spiess E; Schirren J; Ebert W; Fiehn W; Luther T; Magdolen V; Schmitt M; Harbeck N
Anticancer Res; 2004; 24(6):4147-61. PubMed ID: 15736466
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin B in predicting the extent of the cervix carcinoma.
Makarewicz R; Drewa G; Szymanski W; Skonieczna-Makarewicz I
Neoplasma; 1995; 42(1):21-4. PubMed ID: 7617069
[TBL] [Abstract][Full Text] [Related]
18. The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer.
Nishikawa H; Ozaki Y; Nakanishi T; Blomgren K; Tada T; Arakawa A; Suzumori K
Gynecol Oncol; 2004 Mar; 92(3):881-6. PubMed ID: 14984956
[TBL] [Abstract][Full Text] [Related]
19. Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful?
Mori M; Kohli A; Baker SP; Savas L; Fraire AE
Mod Pathol; 1997 Jun; 10(6):572-7. PubMed ID: 9195574
[TBL] [Abstract][Full Text] [Related]
20. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J
J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
